Tadalafil study for pediatric PAH on efficacy, safety and pharmacodynamics

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2011
INTERVENTION: single oral administration of tadalafil 1mg/kg CONDITION: pediatric pulmonary arterial hypertension PRIMARY OUTCOME: tadalafil activity(30min, 1hr, 2hr, 3hr, 4 or 5hr) after administration ; mean pulmonary arterial pressure and pulmonary arterial resistance of the same time points SECONDARY OUTCOME: cyclic GMP level; blood pressure, heart rate ; adverse effects (headache, flushing) INCLUSION CRITERIA: PAH
Epistemonikos ID: ed1c17819247730c2d605ff6f20d74b879945aee
First added on: Aug 22, 2024